Abstract

Mitochondria are intracellular organelles in eukaryotic cells that participate in bioenergy metabolism and cell homeostasis, including ATP generation through electron transport and oxidative phosphorylation in combination with oxidation of metabolites by the tricarboxylic acid cycle and fatty acid catabolism via β-oxidation. the production of reactive oxygen species, as well as the initiation and implementation of apoptosis. Mitochondria play a crucial role in cellular energy metabolism and the regulation of programmed cell death. mitochondria activate numerous signaling pathways associated with cell death. Mitochondria have the ability to control the activation of programmed cell death by regulating the translocation of proapoptotic proteins from the intermediate space of mitochondria to the cytosol. This is the reason for the emergence of a new discipline — mitochondrial medicine. The review examined and analyzed scientific publications on the role of mitochondria in the life support of transformed cells, the study of their functioning and structurally functional dysfunctions, as part of mitochondrial medicine. Mitochondrial medicine is a developing discipline whose significance stems from the central function of mitochondria in the production of adenosine triphosphate, the generation of reactive oxygen species, and cell death due to necrosis or apoptosis. Consequently, mitochondrial dysfunction plays an important role in the pathophysiology of cancer, many other common diseases and side effects of drugs. Perhaps the combined use of modulators of mitochondrial metabolism and antitumor therapy will contribute to the emergence of a new direction in antitumor treatment, which will significantly increase the effectiveness of cancer treatment.

Highlights

  • Актуальность развития митохондриальной меди‐ цины обусловлена расширением представлений о роли и значении митохондрий в патогенезе различ‐ ных заболеваний, в том числе и рака [1, 2]

  • Первый тип мута‐ ций может быть потерян клеткой во время последую‐ щей оксигенации опухоли, в то время как последний тип мутаций может стать для клетки фиксированным [13]

  • Naito A, Cook CC, Mizumachi T, Wang M, Xie CH, Evans TT, et al Progressive tumor features accompany epithelial-mesen‐ chymal transition induced in mitochondrial DNA-depleted cells

Read more

Summary

Introduction

Актуальность развития митохондриальной меди‐ цины обусловлена расширением представлений о роли и значении митохондрий в патогенезе различ‐ ных заболеваний, в том числе и рака [1, 2]. 92-108 E.M.Frantsiyants, I.V.Neskubina, E.A.Sheiko* / Mitochondria of transformed cell as a target of antitumor influence 92-108 Е.М.Франциянц, И.В.Нескубина, Е.А.Шейко* / Митохондрии трансформированной клетки как мишень противоопухолевого воздействия в структурных генах OXPHOS, кодируемых в ядерной ДНК, также могут вызывать митохондриальное забо‐ левание, а изменения в генах митохондриального биогенеза ядерной ДНК могут дестабилизировать мтДНК и приводить к клиническим фенотипам, т.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call